• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食物对奈法唑酮片生物利用度的影响缺乏效应。

The lack effect of food on the bioavailability of nefazodone tablets.

作者信息

Dockens R C, Greene D S, Barbhaiya R H

机构信息

Department of Metabolism and Pharmacokinetics, Bristol-Myers Squibb Company, Pharmaceutical Research Institute, Princeton, NJ, USA.

出版信息

Biopharm Drug Dispos. 1996 Mar;17(2):135-43. doi: 10.1002/(SICI)1099-081X(199603)17:2<135::AID-BDD947>3.0.CO;2-K.

DOI:10.1002/(SICI)1099-081X(199603)17:2<135::AID-BDD947>3.0.CO;2-K
PMID:8907720
Abstract

The objective of this study was to assess the effect of food on the pharmacokinetics of nefazodone (NEF). A group of 24 healthy adult male volunteers received a single 200 mg dose of NEF under fasting conditions as well as 5 min after a high-fat breakfast. There was a 1 week washout between treatments. Serial blood samples were collected for 48 h after dosing and assayed by a validated HPLC method for NEF and the metabolites hydroxynefazodone (HO-NEF), m-chlorophenylpiperazine (mCPP), and triazoledione (dione). The mean (SD) peak concentration (Cmax) for NEF was not affected by food and was 416 (220) ng mL-1 and 446 (271) ng mL-1 after the fed and fasted treatments, respectively. The median time to reach Cmax (Tmax) was also unaffected by food and was 2 h for both treatments. However, the mean (SD) area under the curve (AUC) was significantly reduced by food from 1815 (1017) ng h mL-1 to 1409 (695) ng h mL-1. Although there was an 18% decrease in NEF AUC when administered with food, food had no effect on Cmax and Tmax values for NEF, HO-NEF, mCPP or dione or AUC values for HO-NEF, mCPP, or dione, indicating that NEF can be administered without regard to meals.

摘要

本研究的目的是评估食物对奈法唑酮(NEF)药代动力学的影响。一组24名健康成年男性志愿者在禁食条件下以及高脂早餐后5分钟接受了单次200mg剂量的NEF。两次治疗之间有1周的洗脱期。给药后48小时采集系列血样,并用经过验证的HPLC方法测定NEF及其代谢产物羟基奈法唑酮(HO-NEF)、间氯苯哌嗪(mCPP)和三唑二酮(二酮)。NEF的平均(标准差)峰浓度(Cmax)不受食物影响,进食和禁食治疗后分别为416(220)ng/mL和446(271)ng/mL。达到Cmax的中位时间(Tmax)也不受食物影响,两种治疗均为2小时。然而,食物使曲线下平均(标准差)面积(AUC)显著降低,从1815(1017)ng·h/mL降至1409(695)ng·h/mL。虽然进食时NEF的AUC下降了18%,但食物对NEF、HO-NEF、mCPP或二酮的Cmax和Tmax值以及HO-NEF、mCPP或二酮的AUC值均无影响,这表明NEF给药无需考虑进餐情况。

相似文献

1
The lack effect of food on the bioavailability of nefazodone tablets.食物对奈法唑酮片生物利用度的影响缺乏效应。
Biopharm Drug Dispos. 1996 Mar;17(2):135-43. doi: 10.1002/(SICI)1099-081X(199603)17:2<135::AID-BDD947>3.0.CO;2-K.
2
Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in humans.[14C]奈法唑酮在人体内的药代动力学、绝对生物利用度及处置情况。
Drug Metab Dispos. 1996 Jan;24(1):91-5.
3
Pharmacokinetics, absolute bioavailability, and disposition of [14C]nefazodone in the dog.犬体内[14C]奈法唑酮的药代动力学、绝对生物利用度及处置情况。
Drug Metab Dispos. 1993 May-Jun;21(3):502-7.
4
Absorption and presystemic metabolism of nefazodone administered at different regions in the gastrointestinal tract of humans.奈法唑酮在人体胃肠道不同部位给药后的吸收及首过代谢。
Pharm Res. 1995 Nov;12(11):1716-21. doi: 10.1023/a:1016265705932.
5
Single and multiple dose pharmacokinetics of nefazodone in subjects classified as extensive and poor metabolizers of dextromethorphan.奈法唑酮在被分类为右美沙芬代谢快和代谢慢的受试者中的单剂量及多剂量药代动力学。
Br J Clin Pharmacol. 1996 Nov;42(5):573-81. doi: 10.1111/j.1365-2125.1996.tb00112.x.
6
Assessment of the bioequivalence of two formulations of clarithromycin extended-release 500-mg tablets under fasting and fed conditions: a single-dose, randomized, open-label, two-period, two-way crossover study in healthy Jordanian male volunteers.500毫克克拉霉素缓释片两种制剂在空腹和进食条件下的生物等效性评估:一项在健康约旦男性志愿者中进行的单剂量、随机、开放标签、两周期、双向交叉研究。
Clin Ther. 2008 Oct;30(10):1831-43. doi: 10.1016/j.clinthera.2008.10.010.
7
A study of the effect of age and gender on the pharmacokinetics of nefazodone after single and multiple doses.一项关于年龄和性别对单次及多次给药后奈法唑酮药代动力学影响的研究。
J Clin Psychopharmacol. 1996 Feb;16(1):19-25. doi: 10.1097/00004714-199602000-00004.
8
A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions.一种新的非诺贝特制剂:六项单剂量临床研究在进食和空腹条件下的生物利用度结果。
Clin Ther. 2004 Sep;26(9):1456-69. doi: 10.1016/j.clinthera.2004.09.015.
9
Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalation.奈法唑酮的药代动力学:剂量递增和递减后非线性、个体内变异性及达到稳态血浆浓度时间的评估
Eur J Clin Pharmacol. 1996;50(1-2):101-7. doi: 10.1007/s002280050076.
10
Simultaneous quantitation of d7-nefazodone, nefazodone, d7-hydroxynefazodone, hydroxynefazodone, m-chlorophenylpiperazine and triazole-dione in human plasma by liquid chromatographic-mass spectrometry.采用液相色谱-质谱联用技术同时定量测定人血浆中d7-奈法唑酮、奈法唑酮、d7-羟基奈法唑酮、羟基奈法唑酮、间氯苯哌嗪和三唑二酮。
Biomed Chromatogr. 2000 Apr;14(2):106-12. doi: 10.1002/(SICI)1099-0801(200004)14:2<106::AID-BMC934>3.0.CO;2-0.

引用本文的文献

1
Evaluation of Solubility-Limited Absorption as a Surrogate to Predicting Positive Food Effect of BCS II/IV Drugs.评估溶解度限制吸收作为预测BCS II/IV类药物食物正效应替代指标的研究
Clin Pharmacokinet. 2025 Mar;64(3):373-385. doi: 10.1007/s40262-025-01473-9. Epub 2025 Feb 3.
2
Food effect risk assessment in preformulation stage using material sparing μFLUX methodology.在制剂前阶段使用材料节约型μFLUX方法进行食物效应风险评估。
ADMET DMPK. 2022 Oct 7;10(4):299-314. doi: 10.5599/admet.1476. eCollection 2022.
3
Understanding Mechanisms of Food Effect and Developing Reliable PBPK Models Using a Middle-out Approach.
理解食物效应的机制并采用中间向外方法开发可靠的 PBPK 模型。
AAPS J. 2021 Jan 4;23(1):12. doi: 10.1208/s12248-020-00548-8.
4
A Review of Food-Drug Interactions on Oral Drug Absorption.食物-药物相互作用对口服药物吸收的影响综述
Drugs. 2017 Nov;77(17):1833-1855. doi: 10.1007/s40265-017-0832-z.
5
Effects of food on clinical pharmacokinetics.食物对临床药代动力学的影响。
Clin Pharmacokinet. 1999 Sep;37(3):213-55. doi: 10.2165/00003088-199937030-00003.
6
Clinical pharmacokinetics of nefazodone.奈法唑酮的临床药代动力学
Clin Pharmacokinet. 1997 Oct;33(4):260-75. doi: 10.2165/00003088-199733040-00002.
7
Nefazodone. A review of its pharmacology and clinical efficacy in the management of major depression.奈法唑酮。其治疗重度抑郁症的药理学及临床疗效综述。
Drugs. 1997 Apr;53(4):608-36. doi: 10.2165/00003495-199753040-00006.